維亞生物(01873.HK)預計中期業績實現重大淨虧損
格隆匯 8 月 16日丨維亞生物(01873.HK)公佈,集團預期截至2020年6月30日止6個月實現重大淨虧損,而截至2019年6月30日止6個月則呈報淨利潤。
基於現時可獲得的資料,董事會認為重大淨虧損乃主要由於有關遵照國際財務報告準則發行可轉換債券的特別虧損約人民幣6.5億元。
2020年2月11日,公司全資附屬公司維亞孵化器投資管理有限公司發行由公司擔保的1.8億美元2.50%可轉換債券。根據國際財務報告準則,可轉換債券的嵌入式衍生部分確認為按公平值列入損益的金融負債,而其公平值於各報告日期經參考市值計量。由於公司股份的價格於2020年2月11日至2020年6月30日大幅上升,經參考公司股份市值評估的公平值已大幅增加,而集團預期於本期間確認按公平值列入損益的金融負債增加。虧損人民幣6.5億元主要包括與可轉換債券的嵌入式衍生部分相關的按公平值列入損益的金融負債的有關公平值虧損以及可轉換債券的債務部分的利息開支。
然而,集團預期與去年同期相比,收益將於本期間增加超過35%。扣除與可轉換債券相關的特別虧損,集團預期錄得公司擁有人應占淨利潤增加。
董事會認為,與可轉換債券的嵌入式衍生部分相關的公平值虧損將不會對集團的經營及財務狀況造成不利影響。敬請股東及潛在投資者注意,可轉換債券的嵌入式衍生部分的公平值將因(其中包括)公司股份價格波動而不時變動,及因此屬波動性質。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.